VEGF Inhibition, Hypertension, and Renal Toxicity
Year: 2012
Type: review
Source: Current Oncology Reports
Institution: Mayo Clinic
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: VEGF inhibition, anti-angiogenic therapy, hypertension, nephrotoxicity, proteinuria, thrombotic microangiopathy, congestive heart failure, bevacizumab, tyrosine kinase inhibitors, VEGF receptors, cancer treatment side effects, renal cell carcinoma, non-small cell lung cancer, gastrointestinal stromal tumor, colorectal cancer
Open Access status: green
OpenAlex ID: W2123629654
